WT
PFE icon

Wilmington Trust’s Pfizer PFE Stock Holding History

Wilmington Trust’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$34.8M Sell
1,236,216
-74,478
-6% -$2.12M 0.58% 41
2014
Q1 		$39.9M Sell
1,310,694
-16,160
-1% -$482K 0.69% 32
2013
Q4 		$38.6M Sell
1,326,854
-8,004
-0.6% -$233K 0.65% 33
2013
Q3 		$36.4M Buy
1,334,858
+17,156
+1% +$467K 0.64% 31
2013
Q2 		$35M Buy
+1,317,702
New +$36.4M 0.7% 30

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wilmington Trust's PFE Position: Q2 2014 in Review

Wilmington Trust reduced its Pfizer (PFE) stake by 5.7% in Q2 2014, selling an estimated $2.12M and leaving 1,236,216 shares worth $34.8M. The position accounts for 0.58% of the portfolio, ranked #41.

Wilmington Trust first reported a position in PFE in Q2 2013 and has held it in 5 quarters since. The position peaked at $39.9M in Q1 2014. 1,747 funds tracked by Wall St. Rank hold PFE as of Q2 2014.

  • Wilmington Trust held 1,236,216 shares of Pfizer worth $34.8M as of Q2 2014.
  • Wilmington Trust sold 74,478 Pfizer shares in Q2 2014, an estimated $2.12M.
  • Pfizer made up 0.58% of Wilmington Trust's portfolio in Q2 2014, its #41 holding.
  • Wilmington Trust first reported a position in Pfizer in Q2 2013 and has held it in 5 quarters since.
  • Wilmington Trust's Pfizer position peaked at $39.9M in Q1 2014.
  • 1,747 funds tracked by Wall St. Rank held Pfizer as of Q2 2014.

Based on Wilmington Trust's 13F filing for Q2 2014, filed 13 Aug 2014.